Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
J INTS BIO, poster presentation of further preclinical data of its Novel Oral 4th Generation EGFR-TKI 'JIN-A02' at the 2022 European Society for Medical Oncology Congress in Paris, France (ESMO 2022) 2022-09-15 14:12
United Imaging Announces Clinical System Installations at Huntsman Cancer Institute at the University of Utah 2022-09-14 21:00
Gracell Biotechnologies to Participate in Three Upcoming Investor Conferences 2022-09-14 20:30
DR CATHERINE MOHR TO JOIN BOARD OF MEDTECH COMPANY AROA BIOSURGERY 2022-09-14 13:05
MD ANDERSON AND RADIOPHARM THERANOSTICS LAUNCH JOINT VENTURE TO DEVELOP NOVEL RADIOPHARMACEUTICALS 2022-09-14 11:09
GBB Lands USD 15M Pre-Series B Funding Led by Tiger Jade Capital 2022-09-14 09:08
New Study by Lunit and MGH Validates Effectiveness of AI as Aid in Chest X-Ray Interpretation - Published in JAMA Network Open 2022-09-13 22:16
EDGC (Eone Diagnomics Genome Center) recruits Sam Martin, Vice President of Overseas Business Development... to "accelerate entering the overseas market" 2022-09-13 21:00
I-Mab Announces Approval from China CDE to Initiate Phase 3 Registrational Study of Lemzoparlimab in Combination with Azacitidine in Higher-Risk Myelodysplastic Syndrome 2022-09-13 20:00
First and only TIGIT/TGF-β dual-targeting antibody fusion protein of Akeso demonstrated promise in preclinical results published at ESMO 2022-09-13 14:02
SeekIn Receives CE Mark Approval for OncoSeek® Multi-Cancer Detection Test 2022-09-12 21:37
Origin Agritech Announces Addition to Two FTSE Russell Equity Indices 2022-09-12 20:45
I-Mab Announces Positive Phase 2 Data of Lemzoparlimab in Combination with Azacitidine (AZA) in Patients with Higher Risk Myelodysplastic Syndrome at ESMO 2022 2022-09-10 21:00
Redbud raises $10M in series A round as CRO focusing on science-driven clinical development 2022-09-10 05:13
WuXi STA Opens a New Sterile Lipid Nanoparticle Formulation Facility to Enhance Global CRDMO Services for Customers 2022-09-09 20:00
111 Inc. Receives Unsolicited Preliminary Non-Binding Proposal to Acquire the Company 2022-09-09 17:53
Waterdrop Inc. Announces Second Quarter 2022 Unaudited Financial Results 2022-09-09 16:00
Antengene to Present at Upcoming Industry Conferences 2022-09-09 14:43
Pulnovo Medical Concludes Successfully the First Steering Committee Meeting 2022-09-08 20:30
InxMed Announces First Patient Dosed in Phase 2 Pivotal Study of IN10018 In Patients with Platinum-Resistant Recurrent Ovarian Cancer 2022-09-08 08:00
1 128 129 130 131 132 801